$ACMR

Wang David H sold $748K of ACMR

Wang David H (See Remarks) sold 8,581 shares of ACM Research, Inc. (ACMR) at $87.13 ($0.75M total) on 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wang David H
Published Jun 5, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ACMR
Neutral
medium confidence
Mentioned
$ACMR
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACMRNeutralLow
01

Why it matters

The transaction is disclosed as an open-market sale executed under a pre-arranged Rule 10b5-1 plan, which generally lowers the information content about near-term company prospects.

02

Market read

Traders may monitor for follow-on insider activity, but the 10b5-1 structure makes this more of a routine disclosure than a catalyst.

03

What to watch

The filing does not indicate whether additional insider buys/sales occurred around the same window, nor does it reveal the insider’s cost basis or tax-driven rationale.

Relevance 7/10Novelty 6/10Timing: Filed after-hours/late day (2026-06-05 20:30 UTC) for a 2026-06-04 sale.

Background

This is an SEC Form 4 insider transaction (officer/director/10% owner) reported for ACM Research, Inc.

Company-level read

Ticker impact

$ACMRNeutralMedium confidence
Context

ACMR disclosed an officer/director/10% owner open-market sale of 8,581 shares at $87.13 via a 10b5-1 plan.

Expected impact

Likely limited immediate impact; any effect is more sentiment/flow-related than fundamental.

Evidence & confidence

The filing is a routine Form 4 transaction and explicitly states a pre-arranged 10b5-1 plan, reducing interpretive weight versus discretionary selling.

Market effects

No clear sector read-through; this is company-specific insider activity.

None.

None.

Counterpoint

A 10b5-1 sale can be purely mechanical (liquidity/tax planning) and should not be treated as a bearish signal.

Key entities

  • ACM Research, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Wang David H

    Officer, director, and 10% owner who sold 8,581 shares.

Related articles

$ACMRMed

ACM Research, Inc. Q2 2026 Earnings Call Summary

ACM Research (ACM) reported Q2 2026 revenue up 36% YoY, driven by ECP and advanced packaging categories. The company said it received panel-level horizontal plating orders from two customers and expects full-year 2026 revenue guidance of $1.125B to $1.175B. It noted cleaning revenue fell 14% and net cash exceeds $1B.